NDUFAF5

NDUFAF5 is a mitochondrial complex I assembly factor that functions as a hydroxylase despite possessing a seven-β-strand S-adenosylmethionine (SAM)-dependent methyltransferase fold, catalyzing the hydroxylation of Arg-73 on the NDUFS7 subunit early in complex I biogenesis before junction of the peripheral and membrane arms (PMID:27226634). It is peripherally associated with the matrix face of the mitochondrial inner membrane, and its loss leads to near-complete absence of mature complex I holoenzyme, with a secondary partial deficiency of complex IV (PMID:18940309, PMID:21607760). The catalytic methyltransferase motif is essential for function, as site-directed mutagenesis abolishes complex I assembly in Dictyostelium, and pathogenic patient mutations likewise fail to complement the assembly defect (PMID:23536703, PMID:19542079).

1. 2008 High

   Establishing that a previously uncharacterized open reading frame (C20orf7/NDUFAF5) encodes a mitochondrial inner membrane-associated protein required for early complex I assembly resolved a gap in the known assembly factor repertoire.

   Evidence Subcellular fractionation, RNAi knockdown, Blue Native PAGE, and microcell-mediated chromosome transfer in human fibroblasts

   PMID:18940309

   Open questions at the time

   • Enzymatic activity of NDUFAF5 not identified
   • Specific substrate within complex I unknown
   • Mechanism of early assembly defect not defined
2. 2009 Medium

   Mapping a pathogenic missense mutation (p.L159F) to the predicted SAM-dependent methyltransferase domain linked the catalytic fold to complex I assembly function and implicated possible methylation of NDUFS7 or NDUFB3.

   Evidence Blue Native PAGE and homozygosity mapping in patient fibroblasts

   PMID:19542079

   Open questions at the time

   • No direct enzymatic assay performed to confirm methyltransferase or other catalytic activity
   • Identity of substrate modification not demonstrated biochemically
3. 2011 Medium

   Genetic complementation in patient fibroblasts confirmed NDUFAF5 is essential for complex I activity and revealed an unexpected secondary effect on complex IV, broadening its functional impact beyond complex I alone.

   Evidence Wild-type gene complementation in patient fibroblasts with spectrophotometric enzyme activity assays

   PMID:21607760

   Open questions at the time

   • Mechanism of secondary complex IV deficiency unresolved
   • Whether complex IV effect is direct or indirect not tested
4. 2013 Medium

   Site-directed mutagenesis of the methyltransferase motif in Dictyostelium demonstrated that the catalytic domain is indispensable for complex I assembly function, and revealed an AMPK-independent autophagy response to NDUFAF5 loss.

   Evidence Mutagenesis, genetic complementation, and autophagy/AMPK epistasis assays in Dictyostelium

   PMID:23536703

   Open questions at the time

   • The AMPK-independent autophagy pathway downstream of NDUFAF5 loss not molecularly defined
   • Relevance of autophagy phenotype to mammalian cells not tested
5. 2016 High

   The key mechanistic breakthrough redefined NDUFAF5 as a hydroxylase — not a methyltransferase — that introduces a hydroxyl group at Arg-73 of NDUFS7 during an early assembly intermediate, establishing the precise enzymatic activity and substrate of the factor.

   Evidence Mass spectrometry-based modification site identification and in vitro biochemical assays with assembly intermediate analysis

   PMID:27226634

   Open questions at the time

   • Crystal structure of NDUFAF5 not determined
   • Chemical mechanism of hydroxylation using the SAM-fold not fully elucidated
   • Functional consequence of Arg-73 hydroxylation for complex I catalysis not tested
6. 2022 Medium

   CRISPR knockout of NDUFAF5 in colon cancer cells reduced EMT-mediated migration, proliferation, and xenograft tumor growth, extending its relevance to cancer biology beyond mitochondrial bioenergetics.

   Evidence CRISPR knockout with migration/proliferation assays and xenograft mouse models

   PMID:36421786

   Open questions at the time

   • Whether the cancer phenotype is a direct consequence of complex I deficiency or a separate function not distinguished
   • Not independently replicated in other cancer types
7. 2023 Medium

   An lncRNA-scaffolded interaction between HBB and NDUFAF5 in mitochondria was proposed to suppress ROS and promote chemoresistance in NSCLC, suggesting NDUFAF5 participates in mitochondrial ROS regulation through non-canonical protein partnerships.

   Evidence ChIRP-MS, RNA immunoprecipitation, co-localization imaging, and xenograft validation in NSCLC cells

   PMID:38155279

   Open questions at the time

   • Functional relevance of HBB–NDUFAF5 interaction to complex I assembly or hydroxylase activity unknown
   • Whether ROS suppression is independent of complex I activity not tested
   • Finding from a single lab, not independently confirmed

• The structural basis for how NDUFAF5 uses a SAM-dependent methyltransferase fold to catalyze hydroxylation, the functional consequence of Arg-73 hydroxylation for complex I catalytic performance, and the mechanism underlying the secondary complex IV deficiency remain unresolved.
• No crystal or cryo-EM structure of NDUFAF5 available
• Impact of Arg-73 hydroxylation on complex I electron transfer or proton pumping not measured
• Molecular basis for complex IV secondary deficiency unknown